ELPIDERA

Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics for use in the prevention and treatment of rare diseases of the following systems - skeletal system, muscular system, cardiovascular system, digestive system, endocrine system, nervous system, respiratory system, immune system, lymphatic system, urinary system, female reproductive system, male reproductive system, metabolic system, and the integumentary system